Marc Engelsgjerd, MD

VP, Search and Evaluation at Royalty Pharma

[Marc Engelsgjerd, MD @Engelsgjerd]

@BLLPHD Lugano?

[Marc Engelsgjerd, MD @Engelsgjerd]

@bradloncar That was a short “next few weeks”!

[Marc Engelsgjerd, MD @Engelsgjerd]

@daphnezohar Wondering the same thing myself. Haven’t seen anything official.

[Marc Engelsgjerd, MD @Engelsgjerd]

@bradloncar @BiotechTVHQ Impressive lineup!

[Marc Engelsgjerd, MD @Engelsgjerd]

@Frank_S_David @ByLizC

[Marc Engelsgjerd, MD @Engelsgjerd]

Here’s a video on immune cloaking edits & off-the-shelf #celltherapy for #cancer. #Biotech can't seem to catch a break recently, but it's uplifting to focus on a new wave of cell engineering that could help move this class of therapeutics forward. https://t.co/ikHVzbJSiL

[Bloomberg @business]

MORE: Biotech companies are racing to assess the damage from SVB’s failure.

SVB plays a large role in financing early-stage life-sciences and health-care companies https://t.co/vQmyj6Mooc

[Marc Engelsgjerd, MD @Engelsgjerd]

@formerlyhot The whole thing is confusing.

[Marc Engelsgjerd, MD @Engelsgjerd]

Guerrilla marketing campaign for Vabysmo?

[Marc Engelsgjerd, MD @Engelsgjerd]

@michael_gilman Made a pilgrimage to the Carousel Bar in New Orleans during ASH to have one. The cocktail was excellent but not sure how I felt about the rotating bar!

[Marc Engelsgjerd, MD @Engelsgjerd]

@ideapharma @JacqBarendregt @the_sy_guy @nickisnpdx @eperlste @DavidFajgenbaum @jhoronjeff @cvonraesfeld @takmad @ritters90 🎸👍🏻 #AltJPM

[Marc Engelsgjerd, MD @Engelsgjerd]

Starting in 15 minutes! Please join our @BBGIntelligence #webinar on #Amgen AMG 133 data & the evolving #obesity therapeutic landscape. Registration/access info here: https://t.co/zFCfhC6AoR

[Marc Engelsgjerd, MD @Engelsgjerd]

@BertrandBio Hard core. But in a good way.

[Marc Engelsgjerd, MD @Engelsgjerd]

@bradloncar Here’s hoping their dogs aren’t barking.

[Marc Engelsgjerd, MD @Engelsgjerd]

@BertrandBio Going the wrong way!

[Marc Engelsgjerd, MD @Engelsgjerd]

@BertrandBio EXPAND=70, ALPHA2=100

[Marc Engelsgjerd, MD @Engelsgjerd]

Looking forward to this on the assumption it’s never too late to learn some new tricks. Plus two of my favorite people in biotech! @Frank_S_David @Nfcanavan

[Frank S. David @Frank_S_David]

👀 I’m doing a live (free) Q&A on biotech forecasting & valuation on 10/19!

We’ll discuss modeling rare dz & gene Rx, R&D success rates, best/1st in class, & more!

Sign up: https://t.co/pPbNjnhBvw — hosted by @FirstThoughtIO

DMs open if you want to suggest questions/topics.

[Marc Engelsgjerd, MD @Engelsgjerd]

@bradloncar Just a few minutes to spare… Most expensive drug ever?

[Marc Engelsgjerd, MD @Engelsgjerd]

@bradloncar @BiotechCH @cngarabedian @daphnezohar Great session today, as always! From a user perspective, the two platforms seem equivalent. No issues with audio drop when switching to web browser to look up a company mentioned or to check for breaking @CPFC transfer news…